Detalhe da pesquisa
1.
Fracture risk after intralesional curettage of atypical cartilaginous tumors.
J Orthop Surg Res
; 18(1): 851, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946306
2.
The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
Bone Joint J
; 101-B(3): 272-280, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813787
3.
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
J Bone Joint Surg Am
; 101(14): 1309-1318, 2019 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318811
4.
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.
Sci Rep
; 9(1): 14551, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601938
5.
Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature.
Int J Oral Maxillofac Surg
; 47(10): 1288-1294, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29709323
6.
Severity classification of Tenosynovial Giant Cell Tumours on MR imaging.
Surg Oncol
; 27(3): 544-550, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217317
7.
Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors.
Sarcoma
; 2016: 3072135, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115910